Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fish-net posterior capsular opacification: A newer variant.
Agarwalla I, Bhattacherjee H, Chiraniya P, Garg M. Agarwalla I, et al. Among authors: garg m. Indian J Ophthalmol. 2020 Oct;68(10):2258. doi: 10.4103/ijo.IJO_643_20. Indian J Ophthalmol. 2020. PMID: 32971676 Free PMC article. No abstract available.
Emulsified Silicone Oil Inside the Capsular Bag.
Agarwalla I, Garg M, Bhattacharjee H. Agarwalla I, et al. Among authors: garg m. JAMA Ophthalmol. 2022 Aug 1;140(8):e222429. doi: 10.1001/jamaophthalmol.2022.2429. Epub 2022 Aug 18. JAMA Ophthalmol. 2022. PMID: 35980399 No abstract available.
Pseudoexfoliative Deposits on an Intraocular Lens.
Bhattacharjee H, Mishra S, Garg M. Bhattacharjee H, et al. Among authors: garg m. JAMA Ophthalmol. 2023 Jun 1;141(6):e230407. doi: 10.1001/jamaophthalmol.2023.0407. Epub 2023 Jun 15. JAMA Ophthalmol. 2023. PMID: 37318530
A Spiderweb-Like Fibrinous Reaction.
Agarwalla I, Garg M, Ahir A. Agarwalla I, et al. Among authors: garg m. JAMA Ophthalmol. 2021 Apr 1;139(4):e210697. doi: 10.1001/jamaophthalmol.2021.0697. Epub 2021 Apr 21. JAMA Ophthalmol. 2021. PMID: 33881495 No abstract available.
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.
Cooper N, Jansen AJG, Bird R, Mayer J, Sholzberg M, Tarantino MD, Garg M, Ypma PF, McDonald V, Percy C, Košťál M, Goncalves I, Bogdanov LH, Gernsheimer TB, Diab R, Yao M, Daak A, Kuter DJ. Cooper N, et al. Among authors: garg m. Am J Hematol. 2025 Jan 22. doi: 10.1002/ajh.27539. Online ahead of print. Am J Hematol. 2025. PMID: 39844469
2,152 results